{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:44:34Z","timestamp":1787165074671,"version":"build-2736575974"},"reference-count":68,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":370,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006312","name":"BrightFocus Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21 EY031108"],"award-info":[{"award-number":["R21 EY031108"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 EY032238"],"award-info":[{"award-number":["R01 EY032238"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016958","name":"Office of Research Infrastructure Programs","doi-asserted-by":"publisher","award":["P510D011107"],"award-info":[{"award-number":["P510D011107"]}],"id":[{"id":"10.13039\/100016958","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005595","name":"University of California","doi-asserted-by":"publisher","award":["EY034123"],"award-info":[{"award-number":["EY034123"]}],"id":[{"id":"10.13039\/100005595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005595","name":"University of California","doi-asserted-by":"publisher","award":["U24 EY029904"],"award-info":[{"award-number":["U24 EY029904"]}],"id":[{"id":"10.13039\/100005595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005595","name":"University of California","doi-asserted-by":"publisher","award":["EY033733"],"award-info":[{"award-number":["EY033733"]}],"id":[{"id":"10.13039\/100005595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["P30 EY12576"],"award-info":[{"award-number":["P30 EY12576"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007707","name":"University of California, Davis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007707","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000199","name":"U.S. Department of Agriculture","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000199","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001116","name":"Foundation Fighting Blindness Inc","doi-asserted-by":"publisher","award":["R01 EY029298"],"award-info":[{"award-number":["R01 EY029298"]}],"id":[{"id":"10.13039\/100001116","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001116","name":"Foundation Fighting Blindness Inc","doi-asserted-by":"publisher","award":["R01 EY030431"],"award-info":[{"award-number":["R01 EY030431"]}],"id":[{"id":"10.13039\/100001116","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007862","name":"California National Primate Research Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007862","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ymthe.2024.09.027","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T21:00:45Z","timestamp":1727470845000},"page":"3939-3954","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Safety and efficacy of CRISPR-mediated genome ablation of VEGFA as a treatment for choroidal neovascularization in nonhuman primate eyes"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9282-9999","authenticated-orcid":false,"given":"Tzu-Ni","family":"Sin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Tng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Dragoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sruthi","family":"Ramesh Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Villafuerte-Trisolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sook Hyun","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lien","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie M.","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Ho","family":"Shim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn L.","family":"Pepple","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Resmi","family":"Ravindran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imran H.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ala","family":"Moshiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara M.","family":"Thomasy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3061-3310","authenticated-orcid":false,"given":"Glenn","family":"Yiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2024.09.027_bib1","article-title":"Ocular Angiogenesis","volume":"2015","author":"Dreyfuss","year":"2015","journal-title":"J. Ophthalmol."},{"key":"10.1016\/j.ymthe.2024.09.027_bib2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s40942-017-0084-9","article-title":"Retinal and choroidal angiogenesis: a review of new targets","volume":"3","author":"Cabral","year":"2017","journal-title":"Int. J. Retina Vitreous"},{"key":"10.1016\/j.ymthe.2024.09.027_bib3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.oret.2017.04.004","article-title":"Bevacizumab Injection in Patients with Neovascular Age-Related Macular Degeneration Increases Angiogenic Biomarkers","volume":"2","author":"Cabral","year":"2018","journal-title":"Ophthalmol. Retina"},{"key":"10.1016\/j.ymthe.2024.09.027_bib4","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa054481","article-title":"Ranibizumab for Neovascular Age-Related Macular Degeneration","volume":"355","author":"Rosenfeld","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2024.09.027_bib5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.oret.2019.08.009","article-title":"SD-OCT Predictors of Visual Outcomes after Ranibizumab Treatment for Macular Edema due to Retinal Vein Occlusion","volume":"4","author":"Yiu","year":"2020","journal-title":"Ophthalmol. Retina"},{"key":"10.1016\/j.ymthe.2024.09.027_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fgeed.2020.594984","article-title":"CRISPR technology for ocular angiogenesis","volume":"2","author":"Chung","year":"2020","journal-title":"Front. Genome Ed."},{"key":"10.1016\/j.ymthe.2024.09.027_bib7","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0140-6736(22)00018-6","article-title":"Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials","volume":"399","author":"Wykoff","year":"2022","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.ymthe.2024.09.027_bib8","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0140-6736(22)00010-1","article-title":"Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials","volume":"399","author":"Heier","year":"2022","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.ymthe.2024.09.027_bib9","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ebiom.2016.11.016","article-title":"Phase 2a Randomized Clinical Trial: Safety and Post Hoc Analysis of Subretinal rAAV.sFLT-1 for Wet Age-related Macular Degeneration","volume":"14","author":"Constable","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ymthe.2024.09.027_bib11","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable dual RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2024.09.027_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.oret.2017.09.015","article-title":"Genome Editing in Retinal Diseases using CRISPR Technology","volume":"2","author":"Yiu","year":"2018","journal-title":"Ophthalmol. Retina"},{"key":"10.1016\/j.ymthe.2024.09.027_bib13","doi-asserted-by":"crossref","first-page":"5490","DOI":"10.1167\/iovs.16-20296","article-title":"Genomic Disruption of VEGF-A Expression in Human Retinal Pigment Epithelial Cells Using CRISPR-Cas9 Endonuclease","volume":"57","author":"Yiu","year":"2016","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2024.09.027_bib14","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1167\/iovs.16-19316","article-title":"AAV-mediated CRISPR\/Cas gene editing of retinal cells in vivo","volume":"57","author":"Hung","year":"2016","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2024.09.027_bib15","article-title":"In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni","volume":"8","author":"Kim","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2024.09.027_bib16","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.omtm.2020.01.006","article-title":"Factors Impacting Efficacy of AAV-Mediated CRISPR-Based Genome Editing for Treatment of Choroidal Neovascularization","volume":"17","author":"Chung","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2024.09.027_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2020.570917","article-title":"Comparison of CRISPR\/Cas Endonucleases for in vivo Retinal Gene Editing","volume":"14","author":"Li","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ymthe.2024.09.027_bib18","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.omtn.2022.04.015","article-title":"CRISPR-based VEGF suppression using paired guide RNAs for treatment of choroidal neovascularization","volume":"28","author":"Chung","year":"2022","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2024.09.027_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2021.108754","article-title":"Age-related changes in the rhesus macaque eye","volume":"212","author":"Lin","year":"2021","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ymthe.2024.09.027_bib20","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1167\/tvst.10.6.7","article-title":"Advanced retinal imaging and ocular parameters of the rhesus macaque eye","volume":"10","author":"Lin","year":"2021","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.ymthe.2024.09.027_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-14715-z","article-title":"In vivo multimodal imaging of drusenoid lesions in rhesus macaques","volume":"7","author":"Yiu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2024.09.027_bib22","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1167\/iovs.61.2.32","article-title":"Long-term evolution and remodeling of soft drusen in rhesus macaques","volume":"61","author":"Yiu","year":"2020","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2024.09.027_bib23","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1089\/hum.2020.281","article-title":"Host Immune Responses after Suprachoroidal Delivery of AAV8 in Nonhuman Primate Eyes","volume":"32","author":"Chung","year":"2021","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2024.09.027_bib24","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/IIO.0000000000000366","article-title":"Ocular inflammation and treatment emergent adverse events in retinal gene therapy","volume":"61","author":"Mehta","year":"2021","journal-title":"Int. Ophthalmol. Clin."},{"key":"10.1016\/j.ymthe.2024.09.027_bib25","doi-asserted-by":"crossref","first-page":"7788","DOI":"10.1074\/jbc.271.13.7788","article-title":"The carboxyl-terminal domain (111\u2013165) of vascular endothelial growth factor is critical for its mitogenic potency","volume":"271","author":"Keyt","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2024.09.027_bib26","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.omtm.2020.01.002","article-title":"Suprachoroidal and Subretinal Injections of AAV Using Transscleral Microneedles for Retinal Gene Delivery in Nonhuman Primates","volume":"16","author":"Yiu","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2024.09.027_bib27","doi-asserted-by":"crossref","first-page":"5792","DOI":"10.1167\/iovs.17-22473","article-title":"Superior retinal gene transfer and biodistribution profile of subretinal versus intravitreal delivery of AAV8 in nonhuman primates","volume":"58","author":"Seitz","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2024.09.027_bib28","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1089\/jop.2018.0149","article-title":"Determination of a No Observable Effect Level for Endotoxin Following a Single Intravitreal Administration to Cynomolgus Monkeys","volume":"35","author":"Bantseev","year":"2019","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.ymthe.2024.09.027_bib29","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1089\/hgtb.2013.131","article-title":"Absolute determination of single-stranded and self-complementary adeno-associated viral vector genome titers by droplet digital pcr","volume":"25","author":"Lock","year":"2014","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/j.ymthe.2024.09.027_bib30","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.3389\/fmicb.2019.01570","article-title":"Accurate quantification and characterization of adeno-associated viral vectors","volume":"10","author":"Dobnik","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ymthe.2024.09.027_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.846782","article-title":"Subretinal therapy: technological solutions to surgical and immunological challenges","volume":"9","author":"Ladha","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.ymthe.2024.09.027_bib32","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.omtm.2022.01.011","article-title":"Systemic and local immune responses to intraocular AAV vector administration in non-human primates","volume":"24","author":"Ail","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2024.09.027_bib33","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1016\/j.ymthe.2018.05.025","article-title":"Retinal aav8-rs1 gene therapy for x-linked retinoschisis: initial findings from a phase i\/iia trial by intravitreal delivery","volume":"26","author":"Cukras","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.09.027_bib34","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/mt.2010.258","article-title":"Preclinical Safety Evaluation of AAV2-sFLT01\u2014 A Gene Therapy for Age-related Macular Degeneration","volume":"19","author":"MacLachlan","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.09.027_bib35","series-title":"FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease","year":"2023"},{"key":"10.1016\/j.ymthe.2024.09.027_bib36","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41591-018-0327-9","article-title":"Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10","volume":"25","author":"Maeder","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2024.09.027_bib37","first-page":"3785","article-title":"Safety and efficacy of edit-101 for treatment of CEP290-associated retinal degeneration","volume":"64","author":"Pierce","year":"2023","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2024.09.027_bib38","year":"2022"},{"key":"10.1016\/j.ymthe.2024.09.027_bib39","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/jcp.10246","article-title":"VEGF-TRAP(R1R2) suppresses choroidal neovascularization and VEGF-induced breakdown of the blood-retinal barrier","volume":"195","author":"Saishin","year":"2003","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ymthe.2024.09.027_bib40","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1136\/bjo-2022-321488","article-title":"Subretinal deposits in young patients treated with voretigene neparvovec-rzyl for RPE65-mediated retinal dystrophy","volume":"107","author":"Lopez","year":"2023","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.ymthe.2024.09.027_bib41","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ajo.2018.06.011","article-title":"Two-year results after AAV2-mediated gene therapy for choroideremia: the alberta experience","volume":"193","author":"Dimopoulos","year":"2018","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.ymthe.2024.09.027_bib42","article-title":"Reassessment of hyperautofluorescent rings in retinitis pigmentosa using novel retinal imaging techniques","volume":"32","author":"Cabral","year":"2023","journal-title":"Am. J. Ophthalmol. Case Rep."},{"key":"10.1016\/j.ymthe.2024.09.027_bib43","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/j.ophtha.2019.07.005","article-title":"Concentric macular rings sign in Chediak-Higashi Syndrome","volume":"126","author":"Ramtohul","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ymthe.2024.09.027_bib44","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1001\/jamaophthalmol.2014.1715","article-title":"Concentric macular rings sign in patients with foveal hypoplasia","volume":"132","author":"Cornish","year":"2014","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.ymthe.2024.09.027_bib45","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/BF00407774","article-title":"Concentric \u201cmicrowaves\u201d of Henle\u2019s fiber layer: associated with horizontal folding","volume":"216","author":"Wolter","year":"1981","journal-title":"Albrecht Von Graefes Arch. Klin. Exp. Ophthalmol."},{"key":"10.1016\/j.ymthe.2024.09.027_bib46","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/IAE.0000000000002875","article-title":"The Fingerprint Sign of the Henle Fiber Layer","volume":"41","author":"Griffin","year":"2021","journal-title":"Retina"},{"key":"10.1016\/j.ymthe.2024.09.027_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2022.101135","article-title":"The OCT angular sign of Henle fiber layer (HFL) hyperreflectivity (ASHH) and the pathoanatomy of the HFL in macular disease","volume":"95","author":"Ramtohul","year":"2023","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ymthe.2024.09.027_bib48","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1089\/hum.2018.193","article-title":"Somatic Gene Editing of GUCY2D by AAV-CRISPR\/Cas9 Alters Retinal Structure and Function in Mouse and Macaque","volume":"30","author":"McCullough","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2024.09.027_bib49","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adg8163","article-title":"Inducible nonhuman primate models of retinal degeneration for testing end-stage therapies","volume":"9","author":"Ail","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ymthe.2024.09.027_bib50","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.omtm.2020.08.007","article-title":"Generation of Nonhuman Primate Model of Cone Dysfunction through In Situ AAV-Mediated CNGB3 Ablation","volume":"18","author":"Lin","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2024.09.027_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2023.100453","article-title":"Aqueous Macrophages Contribute to Conserved CCL2 and CXCL10 Gradients in Uveitis","volume":"4","author":"Lin","year":"2024","journal-title":"Ophthalmol. Sci."},{"key":"10.1016\/j.ymthe.2024.09.027_bib52","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1167\/iovs.61.10.20","article-title":"CNTF Prevents Development of Outer Retinal Neovascularization Through Upregulation of CxCl10","volume":"61","author":"Bucher","year":"2020","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2024.09.027_bib53","doi-asserted-by":"crossref","first-page":"9478","DOI":"10.1167\/iovs.11-8353","article-title":"Expression and Role of VEGF in the Adult Retinal Pigment Epithelium","volume":"52","author":"Ford","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2024.09.027_bib54","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2211690119","article-title":"Vegf signaling between M\u00fcller glia and vascular endothelial cells is regulated by immune cells and stimulates retina regeneration","volume":"119","author":"Mitra","year":"2022","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ymthe.2024.09.027_bib55","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.visres.2017.05.005","article-title":"VEGF production and signaling in M\u00fcller glia are critical to modulating vascular function and neuronal integrity in diabetic retinopathy and hypoxic retinal vascular diseases","volume":"139","author":"Le","year":"2017","journal-title":"Vis. Res."},{"key":"10.1016\/j.ymthe.2024.09.027_bib56","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.oret.2021.03.016","article-title":"Perifoveal chorioretinal atrophy following subretinal voretigene neparvovec-rzyl for RPE65-mediated leber congenital amaurosis","volume":"6","author":"Gange","year":"2022","journal-title":"Ophthalmol. Retina"},{"key":"10.1016\/j.ymthe.2024.09.027_bib57","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.molcel.2014.08.002","article-title":"Chromosomal translocations in human cells are generated by canonical nonhomologous end-joining","volume":"55","author":"Ghezraoui","year":"2014","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ymthe.2024.09.027_bib58","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/nprot.2016.043","article-title":"Detecting DNA double-stranded breaks in mammalian genomes by linear amplification-mediated high-throughput genome-wide translocation sequencing","volume":"11","author":"Hu","year":"2016","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ymthe.2024.09.027_bib59","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/s41587-020-0561-9","article-title":"Genome editing with CRISPR\u2013Cas nucleases, base editors, transposases and prime editors","volume":"38","author":"Anzalone","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2024.09.027_bib60","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1093\/nar\/gkz605","article-title":"Delivering Cas9\/sgRNA ribonucleoprotein (RNP) by lentiviral capsid-based bionanoparticles for efficient \u201chit-and-run\u201d genome editing","volume":"47","author":"Lyu","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2024.09.027_bib61","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41551-020-00656-y","article-title":"Lentiviral delivery of co-packaged Cas9 mRNA and a Vegfa-targeting guide RNA prevents wet age-related macular degeneration in mice","volume":"5","author":"Ling","year":"2021","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.ymthe.2024.09.027_bib62","series-title":"Retinal Degeneration: Methods and Protocols Methods in Molecular Biology","first-page":"351","article-title":"Adeno-associated viral vectors for gene therapy of inherited retinal degenerations","author":"Flannery","year":"2013"},{"key":"10.1016\/j.ymthe.2024.09.027_bib63","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/978-1-4939-9139-6_4","article-title":"Quantitative and digital droplet-based AAV genome titration","volume":"1950","author":"Sanmiguel","year":"2019","journal-title":"Methods Mol. Biol. 1950"},{"key":"10.1016\/j.ymthe.2024.09.027_bib64","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop","volume":"140","author":"Jabs","year":"2005","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.ymthe.2024.09.027_bib65","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.ajo.2010.05.036","article-title":"Scale for photographic grading of vitreous haze in uveitis","volume":"150","author":"Davis","year":"2010","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.ymthe.2024.09.027_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exer.2019.03.020","article-title":"Repeated retinal photocoagulation in monkeys for the optimization of a laser-induced choroidal neovascularization model","volume":"184","author":"Lin","year":"2019","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ymthe.2024.09.027_bib67","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.exer.2011.03.006","article-title":"Optimization of laser-induced choroidal neovascularization in African green monkeys","volume":"92","author":"Goody","year":"2011","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ymthe.2024.09.027_bib68","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1167\/iovs.18-24192","article-title":"Comparison of Aqueous and Vitreous Lymphocyte Populations From Two Rat Models of Experimental Uveitis","volume":"59","author":"Pepple","year":"2018","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2024.09.027_bib69","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1001\/jamaophthalmol.2018.6902","article-title":"Immune response and intraocular inflammation in patients with leber hereditary optic neuropathy treated with intravitreal injection of recombinant adeno-associated virus 2 carrying the nd4 gene","volume":"137","author":"Bouquet","year":"2019","journal-title":"JAMA Ophthalmol."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001624006518?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001624006518?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T13:43:47Z","timestamp":1786023827000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001624006518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":68,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S1525001624006518"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.09.027","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and efficacy of CRISPR-mediated genome ablation of VEGFA as a treatment for choroidal neovascularization in nonhuman primate eyes","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.09.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The American Society of Gene and Cell Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}